Director/PDMR Shareholding

RNS Number : 8974K

Dechra Pharmaceuticals PLC

19 December 2018

 

19 December 2018

Dechra Pharmaceuticals PLC

Notification of Transactions by Persons Discharging Managerial Responsibilities

Dechra Pharmaceuticals PLC has been notified that on 18 December 2018 Tony Griffin, Director, sold 5,000 ordinary shares in the Company at a price of £21.1537 each. 

Following this disposal, Tony Griffin's beneficial interest in the Company is 70,606 shares (0.069% of the current issued share capital).

The Notification of Dealing Form set out below is provided in accordance with Article 19.3 of MAR.

Notification of Dealing Form:

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Tony Griffin
2.	Reason for the notification
a)	Position/status	Director
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Sale of Shares
c)	Price(s) and volumes(s)	Price(s) £21.1537	Volume(s) 5,000
d)	Aggregated information -  Aggregate volume -   Price -   Total	5,000 £21.1537 £105,768.50
e)	Date of the transaction	18 December 2018
f)	Place of the transaction	London Stock Exchange

For further information, please contact:

Melanie Hall, Company Secretary

Dechra Pharmaceuticals PLC

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHFKFDQOBDDOBD